Similar Search Results

The Therapeutic Consequences of the War : World War II and the 20th-Century Expansion of Biomedicine

Gross, Daniel P.; Sampat, Bhaven N. - National Bureau of Economic Research - 2025

imprint on the postwar U.S. biomedical innovation system. Research areas it supported experienced rapid growth in postwar …

Persistent link: https://www.econbiz.de/10015326451

Crisis Innovation Policy from World War II to COVID-19

Gross, Daniel P.; Sampat, Bhaven N. - National Bureau of Economic Research - 2021

Innovation policy can be a crucial component of governments' responses to crises. Because speed is a paramount … objective, crisis innovation may also require different policy tools than innovation policy in non-crisis times, raising … distinct questions and tradeoffs. In this paper, we survey the U.S. policy response to two crises where innovation was crucial …

Persistent link: https://www.econbiz.de/10012585399

The Economics of Crisis Innovation Policy : A Historical Perspective

Gross, Daniel P.; Sampat, Bhaven N. - National Bureau of Economic Research - 2021

-produced penicillin, antimalarials, and a flu vaccine. We draw on this episode to discuss the economics of crisis innovation. Since the …

Persistent link: https://www.econbiz.de/10012482553

The Rise of Absorptive Research in Corporate America : 1945-1980

Arora, Ashish; Belenzon, Sharon; Suh, Jungkyu; Zhang, Hansen - National Bureau of Economic Research - 2025

transformed the American innovation landscape, deepening the division of innovative labor between universities, startups, and …

Persistent link: https://www.econbiz.de/10015398165

The NBER Orange Book Dataset : A User's Guide

Durvasula, Maya; Hemphill, C. Scott; Ouellette, Lisa … - National Bureau of Economic Research - 2022

This paper introduces a newly digitized, open-access version of the Food and Drug Administration's "Orange Book"--a linkage between approved small-molecule drugs and the patents that protect them. The Orange Book also reports any applicable regulatory exclusivity that prevents competitive entry....

Persistent link: https://www.econbiz.de/10013462677

First-mover Advantage and the Private Value of Public Science

Arora, Ashish; Belenzon, Sharon; Dionisi, Bernardo - National Bureau of Economic Research - 2021

Technical progress increasingly relies on the use of scientific knowledge. But if much of this knowledge is in the public domain, can it be a source of private value? We find that average private returns to using public science are small, especially in crowded technical fields, consistent with...

Persistent link: https://www.econbiz.de/10012496086

Science and the Market for Technology

Arora, Ashish; Belenzon, Sharon; Suh, Jungkyu - National Bureau of Economic Research - 2021

Well functioning Markets for Technology (MFT) allow inventors to sell their inventions to others that may derive more value from them. We argue that the growing reliance on science in inventions enhances MFT. In addition to higher quality inventions, reliance on science may enhance gains from...

Persistent link: https://www.econbiz.de/10012496087

The Effect of Public Science on Corporate R&D

Arora, Ashish; Belenzon, Sharon; Cioaca, Larisa C.; … - National Bureau of Economic Research - 2023

innovation in firms. However, inventions from universities and public research institutes substitute for corporate inventions and …

Persistent link: https://www.econbiz.de/10014437030

Revisiting the Private Value of Scientific Inventions

Arora, Ashish; Belenzon, Sharon; Ferracuti, Elia; … - National Bureau of Economic Research - 2024

Estimating the private value of patents is important, yet challenging. By developing a method that uses stock market returns to produce a distribution of patent values (and not just an estimate of the mean of that distribution), Kogan, Papanikolaou, Seru, and Stoffman (2017) (KPSS) opened venues...

Persistent link: https://www.econbiz.de/10015145046